Screener
Rapport Therapeutics, Inc. RAPP Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For The Six Months Ended June 30, 2026 | For The Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.19) | $(0.75) | $(1.61) | $(1.44) |
| Weighted-average common shares outstanding, basic and diluted | 47,473,174 | 35,444,635 | 47,355,550 | 35,356,098 |
| Comprehensive loss: | ||||
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Change in unrealized (losses) gains on investments, net of tax | (765) | 19 | (1,816) | 446 |
| Total other comprehensive income (loss) | (765) | 19 | (1,816) | 446 |
| Comprehensive loss | $(57,380) | $(26,713) | $(78,288) | $(50,349) |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Rapport Therapeutics, Inc. (RAPP) reported comprehensive income (loss), net of tax, attributable to parent of -$57.38M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 114.8% year-over-year, from -$26.71M to -$57.38M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 78.2% compound annual growth rate (CAGR), from -$34.78M to -$110.42M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources during the period, encompassing both net income and other comprehensive income items. It provides a more holistic view of financial performance by including unrealized gains and losses that are excluded from the traditional income statement. Analysts use this to assess the total impact of market fluctuations and accounting adjustments on the company's overall net worth.
Ask your AI about Rapport Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude